Havana, Cuba

Mario Pablo Estrada García

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Centro De Ingenieria Genetica Y Biotecnologia. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mario Pablo Estrada García. Retrieved from https://idiyas.com/inventor/mario-pablo-estrada-garcía

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Mario Pablo Estrada García

Introduction

Mario Pablo Estrada García is an accomplished inventor based in Havana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of vaccine adjuvants. His work focuses on enhancing immune responses to various infectious agents affecting mammals, birds, and aquatic organisms.

Latest Patents

Mario holds a patent for the "Use of a growth hormone secretagogue peptide as a vaccine adjuvant." This invention relates to the use of GHRP-6 and its structural analogue as molecular adjuvants for vaccines. These vaccines are designed to prevent diseases caused by infectious agents, including viruses and bacteria. The GHRP-6 and its analogue A233 are effective when combined with specific antigens, as they enhance the immune response against these pathogens.

Career Highlights

Mario is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to innovate in the field of genetic engineering and biotechnology. His work has the potential to significantly impact public health by improving vaccine efficacy.

Collaborations

Some of his notable coworkers include Rebeca Martínez Rodríguez and Liz Hernandez Perez. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Mario Pablo Estrada García is a notable inventor whose work in vaccine adjuvants showcases the importance of innovation in biotechnology. His contributions are vital for enhancing immune responses and preventing infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…